Amanote Research
Register
Sign In
Treatment of Linear Scleroderma With Oral 1,25-Dihydroxyvitamin D3 (Calcitriol) in Seven Children
Pediatric Dermatology
- United Kingdom
doi 10.1046/j.1525-1470.1999.99016.x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Dermatology
Child Health
Pediatrics
Perinatology
Date
January 1, 1999
Authors
Unknown
Publisher
Wiley
Related search
Points: 1,25 Dihydroxyvitamin D3 in Psoriasis
BMJ
Analysis of 1,25-Dihydroxyvitamin D3 Receptors (VDR. In Basal Cell Carcinomas
American Journal of Pathology
Forensic Medicine
Pathology
Defective Binding and Function of 1,25-Dihydroxyvitamin D3 Receptors in Peripheral Mononuclear Cells of Patients With End-Organ Resistance to 1,25-Dihydroxyvitamin D.
Journal of Clinical Investigation
Medicine
Recruitment, Augmentation and Apoptosis of Rat Osteoclasts in 1,25-(Oh)2d3 Response to Short-Term Treatment With 1,25-Dihydroxyvitamin D3 in Vivo
BMC Musculoskeletal Disorders
Rheumatology
Orthopedics
Sports Medicine
Prevention of Autoimmune Diabetes in NOD Mice by 1,25 Dihydroxyvitamin D3
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Induction of Monocytic Differentiation and Bone Resorption by 1,25-Dihydroxyvitamin D3.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Regulatory Effects of 1,25-Dihydroxyvitamin D3 on Vascular Smooth Muscle Cells.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Renal Osteodystrophy in Children: Therapy With Vitamin D3 or 1,25 Dihydroxy-Cholecalciferol (1,25-Dhcc)
Pediatric Research
Child Health
Pediatrics
Perinatology
Characterization of a Receptor-Like Protein for 1,25-Dihydroxyvitamin D3 in Rat Skin.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
